Weight Reduction and Improvement in Diabetes by the Duodenal-Jejunal Bypass Liner: a 198 Patient Cohort Study

Treatment with the DJBL in T2DM patients with (morbid) obesity results in improvement in glucose control, a reduction in anti-diabetic medication, and significant weight loss. The largest changes are observed within the first 3-6 months. Initial C-peptide levels and body weight may help to select patients with the greatest chance of success.